Insertion of a genomic fragment of chromosome 19 between BCR intron 19 and ABL intron 1a in a chronic myeloid leukaemia patient with μ-BCR-ABL (e19a2) transcript

British Journal of Haematology

Volumn 126, Issue 5, 2004, Pages 752-753

  Ito, Takuo ^a   Tanaka, Hideo ^a   Tanaka, Kimio ^b   Ito, Kinro ^a   Kyo, Taiichi ^c   Dohy, Hiroo ^c   Kamada, Nanao ^d   Kimura, Akiro ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b INSTITUTE FOR ENVIRONMENTAL SCIENCES   (Japan)

^c ATOMIC BOMB SURVIVORS HOSPITAL   (Japan)

^d Hiroshima Atomic Bomb Survivors Nursing Home   (Japan)

Author keywords

BCR ABL; Blast crisis; Chronic myeloid leukaemia; e19a2

Indexed keywords

BCR ABL PROTEIN;

CHROMOSOME 19; CHRONIC MYELOID LEUKEMIA; GENOMIC FRAGMENT; HUMAN; INTRON; LETTER; MUTATION; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; CHROMOSOME FRAGILITY; CHROMOSOMES, HUMAN, PAIR 19; CHRONIC DISEASE; FEMALE; FUSION PROTEINS, BCR-ABL; GENOME; HUMANS; INTRONS; LEUKEMIA, MYELOID;

EID: 4544343674     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2004.05119.x     Document Type: Letter

References (6)

1. Arana-Trejo, R.M., S'anchez, E.R., Ignacio-Ibarra, G., Báez de la Fuente, E., Garces, O., Gómez Morales, E., Castro Granados, M., Ovilla Martínez, R., Rubio-Borja, M.E., Solís Anaya, L., Herrera, P., Delgado Llamas, J. & Kofman, S. (2002) BCR/ABL p210, p190 and p230 fusion genes in 250 Mexican patients with chronic myeloid leukaemia (CML). Clinical and Laboratory Haematology, 24, 145-150.
2. Liu, L-G., Tanaka, H., Ito, K., Kyo, T., Ito, T. & Kimura, A. (2003) Chronic myelogenous leukemia with e13a3 (b2a3) type of BCR-ABL transcript having a DNA breakpoint between ABL exons a2 and a3. American Journal of Hematology, 74, 268-272.
3. Melo, J.V. (1997) BCR-ABL gene variants. Baillière's Clinical Haematology, 10, 203-222.
4. Saglio, G., Guerrasio, A., Rosso, C., Zaccaria, A., Tassinari, A., Serra, A., Rege-Cambrin, G., Mazza, U. & Gavosto, F. (1990) New type Bcr/Abl junction in Philadelphia chromosome-positive chronic myelogenous leukemia. Blood, 76, 1819-1824.
5. Tanaka, K., Hashimoto, T., Oguma, N., Dohy, H. & Kamada, N. (1993) Influence of M-BCR breakpoint sites on the duration of chronic phase in 100 patients with chronic myelocytic leukemia. Cancer Genetics and Cytogenetics, 70, 39-47.
6. Verstovsek, S., Lin, H., Kantarjian, H., Saglio, G., de Micheli, D., Pane, F., Garcia-Manero, G., Intrieri, M., Rotoli, B., Salvatore, F., Guo, J.Q., Talpaz, M., Specchia, G., Pizzolo, G., Liberati, A.M., Cortes, J., Quackenbush, R.C. & Arlinghaus, R.B. (2002) Neutrophilic-chronic myeloid leukemia. Low levels of p230 BCR/ABL mRNA and undetectable p230 BCR/ABL protein may predict an indolent course. Cancer, 94, 2416-2425.